Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19

Affiliations

• ¹ Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
• ² ICES, Toronto, ON, Canada.
• ³ Centre for Vaccine Preventable Diseases, University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada.
• ⁴ Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
• ⁵ Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
• ⁶ Department of Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
• ⁷ Department of Internal Medicine/Section General Medicine, Yale University School of Medicine, New Haven, CT, USA.
• ⁸ Department of Hematology, Yale University School of Medicine, New Haven, CT, USA.
• ⁹ Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.
• ¹⁰ Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.
• ¹¹ Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA.
• ¹² Department of Pediatric, Section of Infectious Diseases and Global Health, Yale University School of Medicine, New Haven, CT, USA.
• ¹³ Yale Institute for Global Health, Yale University, New Haven, CT, USA.
• ¹⁴ Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.
• ¹⁵ Howard Hughes Medical Institute, Chevy Chase, MD, USA. akiko.iwasaki@yale.edu.